denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Symposia: Scientific Workshop on Mitochondria and Metabolism in Blood Cancer- From Worms to Patients
Program: Scientific Workshops
Friday, December 8, 2023: 2:00 PM-2:10 PM
Room 24
(San Diego Convention Center)
Moderators:
Aaron D. Schimmer, MD, Princess Margaret Hospital, University of Toronto
and
Marina Y. Konopleva, Albert Einstein College of Medicine
Disclosures:
Schimmer: UHN: Patents & Royalties: the use of DNT cells to treat AML; Otsuka Pharmaceuticals: Consultancy, Honoraria; Jazz: Consultancy, Honoraria; Novartis: Consultancy, Honoraria; Medivir AB: Research Funding; Takeda Pharmaceuticals: Consultancy, Honoraria, Research Funding; BMS: Research Funding; Medical and Scientific Advisory Board of the Leukemia and Lymphoma Society of Canada: Membership on an entity's Board of Directors or advisory committees. Konopleva: Reata Pharmaceuticals.: Current holder of stock options in a privately-held company, Patents & Royalties; AbbVie, AstraZeneca, Genentech, Gilead, Janssen, MEI Pharma, Sanofi Aventis, Stemline-Menarini, Vincerx: Consultancy; AbbVie, Ablynx, Allogene, AstraZeneca, Cellectis, Daiichi, FortySeven, Genentech, Gilead, Immunogen, MEI Pharma, Precision Biosciences, Rafael Pharmaceutical, Sanofi Aventis, Stemline-Menarini: Research Funding.
opening remarks